164 related articles for article (PubMed ID: 7455991)
1. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro.
Livio M; Rajtar G; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991
[TBL] [Abstract][Full Text] [Related]
2. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
Rajtar G; Livio M; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid-induced malondialdehyde formation in rat platelets. Kinetic aspects and inhibition by acetylsalicylic acid and indomethacin.
de Gaetano G; Rajtar G; Livio M; Merino J
Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):85-9. PubMed ID: 7393351
[TBL] [Abstract][Full Text] [Related]
4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
5. Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
Cerletti C
Int J Tissue React; 1985; 7(4):309-12. PubMed ID: 3934097
[TBL] [Abstract][Full Text] [Related]
6. Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].
Gordon JL; MacIntyre DE; McMillan RM
Br J Pharmacol; 1976 Oct; 58(2):299P-300P. PubMed ID: 974415
[No Abstract] [Full Text] [Related]
7. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
Busse WD; Seuter F
Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
[TBL] [Abstract][Full Text] [Related]
8. The recovery of platelet malondialdehyde production after a single intake of aspirin--the effect of dosage.
Takayama H; Okuma M; Uchino H
Thromb Haemost; 1982 Aug; 48(1):13-7. PubMed ID: 6813990
[TBL] [Abstract][Full Text] [Related]
9. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation.
Torsellini A; Doni L; Palinski W; Guidi G; Lombardi V
Thromb Haemost; 1984 Aug; 52(1):4-6. PubMed ID: 6238444
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity.
Livio M; Del Maschio A; Cerletti C; de Gaetano G
Prostaglandins; 1982 Jun; 23(6):787-96. PubMed ID: 6812166
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
[No Abstract] [Full Text] [Related]
12. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
Sullivan JM; Taylor JC; Samaha JK
Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
[TBL] [Abstract][Full Text] [Related]
13. The chemiluminescence response of human platelets.
Mills EL; Gerrard JM; Filipovich D; White JD; Quie PG
J Clin Invest; 1978 Mar; 61(3):807-14. PubMed ID: 641157
[TBL] [Abstract][Full Text] [Related]
14. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptives.
Hellstern P; Miyashita C; Köhler M; Wenzel E; Holl W
Thromb Haemost; 1982 Dec; 48(3):325-6. PubMed ID: 7164021
[TBL] [Abstract][Full Text] [Related]
17. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
Pönicke K; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hydralazine on the formation of malondialdehyde in platelet-rich plasma and aortic rings in the rat].
Cano E; Orallo F; Cadavid I
Arch Farmacol Toxicol; 1986 Apr; 12(1):49-55. PubMed ID: 3090953
[No Abstract] [Full Text] [Related]
19. In vitro and in vivo effects of ditazol on human platelets malonylaldehyde (MDA) production.
Fabris F; Casonato A; Randi M; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):433-8. PubMed ID: 6169605
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
